Company · CIK 0001853921 · SIC 2836 — Biological Products, (No Diagnostic Substances)
Scribe Therapeutics, Inc. · SCTX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 PForm 4 → | Jul 29, 7:09 pm EDT | AH Bio Fund II, L.P. +510% Owner | 333,333 | $15.00 | $4,999,995 | 2,385,075 | +16.2% | |
| Jul 27, 2026 CForm 4 → | Jul 29, 7:09 pm EDT | AH Bio Fund II, L.P. +510% Owner | 2,749,392 | — | — | 697,650 | — | |
| Jul 27, 2026 PForm 4 → | Jul 29, 6:50 pm EDT | Carl L GordonDirector | 1,000,000 | $15.00 | $15,000,000 | 1,348,825 | +287% | |
| Jul 27, 2026 CForm 4 → | Jul 29, 6:50 pm EDT | Carl L GordonDirector | 348,825 | — | — | 348,825 | — | |
| Jul 27, 2026 PForm 4 → | Jul 29, 6:47 pm EDT | ORBIMED ADVISORS LLC +1Director | 1,000,000 | $15.00 | $15,000,000 | 1,348,825 | +287% | |
| Jul 27, 2026 CForm 4 → | Jul 29, 6:47 pm EDT | ORBIMED ADVISORS LLC +1Director | 348,825 | — | — | 348,825 | — | |
| Jul 27, 2026 CForm 4 → | Jul 29, 4:21 pm EDT | Jennifer A Doudna10% Owner | 12,511 | — | — | 603,547 | — | |
| Jul 24, 2026 PForm 4 → | Jul 28, 9:30 pm EDT | Behzad Aghazadeh +2Director, 10% Owner | 2,391,238 | $15.16 | $36,259,761 | 3,088,888 | +343% | |
| Jul 23, 2026 PForm 4 → | Jul 27, 9:42 pm EDT | Svetlana LucasChief Business Officer | 3,000 | $15.00 | $45,000 | 3,000 | — | |
| Jul 23, 2026 PForm 4 → | Jul 27, 9:20 pm EDT | David ParrotChief Financial Officer | 2,666 | $15.00 | $39,990 | 1,333 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 CForm 4 → | Jul 29, 7:09 pm EDT | AH Bio Fund II, L.P. +510% Owner | 16,281,347 | — | — | 0 | — | |
| Jul 27, 2026 CForm 4 → | Jul 29, 6:50 pm EDT | Carl L GordonDirector | 2,065,672 | — | — | 0 | — | |
| Jul 27, 2026 CForm 4 → | Jul 29, 6:47 pm EDT | ORBIMED ADVISORS LLC +1Director | 2,065,672 | — | — | 0 | — | |
| Jul 27, 2026 CForm 4 → | Jul 29, 4:21 pm EDT | Jennifer A Doudna10% Owner | 74,088 | — | — | 0 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 9:25 pm EDT | Carl L GordonDirector | 14,725 | — | — | 14,725 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 9:23 pm EDT | James Dean WatsonDirector | 14,725 | — | — | 14,725 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 9:22 pm EDT | Joshua BleharskiDirector | 14,725 | — | — | 14,725 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 9:04 pm EDT | Behzad Aghazadeh +2Director | 14,725 | — | — | 14,725 | — | |
| Mar 13, 2026 AForm 4 → | Jul 28, 4:46 pm EDT | Brett Staahl10% Owner | 43,525 | — | — | 19,385 | — | late |
| Mar 13, 2026 AForm 4 → | Jul 27, 9:42 pm EDT | Svetlana LucasChief Business Officer | 228,399 | — | — | 109,426 | — | late |
| Mar 13, 2026 AForm 4 → | Jul 27, 9:26 pm EDT | Benjamin L. OakesPresident, CEO, Director | 707,352 | — | — | 429,599 | — | late |
| Mar 13, 2026 AForm 4 → | Jul 27, 9:20 pm EDT | David ParrotChief Financial Officer | 227,761 | — | — | 109,426 | — | late |